|
| Tuesday, October 4, 2022 |
|
|
Bio Farma secures Multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2) |
| PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export its novel Oral Polio Vaccine type 2 (nOPV2) having secured a purchase contract with the United Nations Children's Fund (UNICEF) for 2022 & 23. Under the contract, Bio Farma will export its oral polio vaccines based on purchase requests from UNICEF via multilateral contract agreement for the years 2022 & 23 more info >> |
|
| Friday, September 30, 2022 |
|
|
Bio Farma to Export its Polio Vaccine After Securing Purchase Contracts from UNICEF for 2022 and 2023 |
| PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOE), will export its novel Oral Polio Vaccine type 2 (nOPV2) having secured a purchase contract with the United Nations Children's Fund (UNICEF) for 2022&23. more info >> |
|
| Tuesday, September 13, 2022 |
|
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Friday, September 9, 2022 |
|
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Friday, May 1, 2015 |
|
|
9th International Conference on Typhoid, Invasive NTS Disease Held in Bali, Indonesia |
| The Coalition against Typhoid (CaT), in collaboration with Bio Farma, began the 9th International Conference on Typhoid and Invasive NTS Disease in Bali, Indonesia, with more than 200 public health experts from around the world in attendance. more info >> |
|
| Tuesday, December 9, 2014 |
|
|
Bio Farma Rolls Out Pentavalent Vaccine to All Provinces of Indonesia in 2014 |
| The Indonesian Ministry of Health introduced Bio Farma's Pentavalent vaccine into the immunization program in 2013, and in 2014 rolled the vaccine out across the 33 provinces of the vast archipelago. more info >> |
|
| Friday, December 5, 2014 |
|
|
Bio Farma Continues Presidency of the Developing Country Vaccine Manufacturers Network (DCVMN) |
| Mahendra Suhardono, Marketing Director of Bio Farma, has become DCVMN President for 2014 - 2016 at the 15th Annual General Meeting of DCVMN / Developing Country Vaccine Manufacturers Network in New Delhi, India, on 27 - 29 October 2014. more info >> |
|
| Thursday, December 4, 2014 |
|
|
Bio Farma Awarded Gold PROPER by the Indonesian Ministry Of Environment & Forestry |
| The award was presented by the Vice President of Indonesia Jusuf Kalla to the President Director of Bio Farma Iskandar on 2nd December 2014, at the Manggala Wanabakti Auditorium of the Ministry of Environment of the Republic of Indonesia. more info >> |
|
| Wednesday, October 23, 2013 |
|
|
Indonesia as the Hub of Excellence for Biological Products for Islamic Countries |
| Jakarta, October 21-24, 2013, the 4th Conference of the Organization of Islamic Cooperation (OIC) Ministers of Health or the Organization of Islamic Cooperation Strategic Health Programme of Action (OIC-SHPA) will be held in Jakarta. more info >> |
|
| Saturday, August 24, 2013 |
|
|
Bio Farma Launches Pentavalent Vaccine, Combining Five Antigens |
| The Indonesian Ministry of Health will introduce a new immunization program, and a pentavalent vaccine for babies aged 2 months to 1 year. One shot of the pentavalent vaccine will prevent babies from five diseases at once, including Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B. more info >> |
|
|
|
